Evidence map›Paper›PMID 27769168›Full record

ArticleBMC genomics2016

Comparative genomics of Clostridium bolteae and Clostridium clostridioforme reveals species-specific genomic properties and numerous putative antibiotic resistance determinants.

Pierre Dehoux, Jean Christophe Marvaud, Amr Abouelleil, Ashlee M Earl, Thierry Lambert, Catherine Dauga

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 69 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. The gut-joint axis in osteoarthritis.Nature reviews. Rheumatology · 2026
    Review
  5. Gut microbes reports · 2026
    Article
  6. Article
  7. Co-Colonization of Non-Antibiotics (Basel, Switzerland) · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Microbiome-based risk prediction in incident heart failure: a community challenge.medRxiv : the preprint server for health sciences · 2023
    Article
  17. Ethanol-ProducingMicroorganisms · 2023
    Article
  18. Characterization of vancomycin-resistanceJAC-antimicrobial resistance · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Pierre DehouxDepartment of Genomes and Genetics, Institut Pasteur, Paris, France.
Jean Christophe MarvaudFaculté de Pharmacie, EA4043 "Unité Bactéries Pathogènes et Santé" (UBaPS), Université Paris Sud, Châtenay-Malabry Cedex, 92296, France.
Amr AbouelleilGenome Sequencing and Analysis Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Ashlee M EarlGenome Sequencing and Analysis Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Thierry LambertFaculté de Pharmacie, EA4043 "Unité Bactéries Pathogènes et Santé" (UBaPS), Université Paris Sud, Châtenay-Malabry Cedex, 92296, France.
Catherine DaugaDepartment of Genomes and Genetics, Institut Pasteur, Paris, France. catherine.dauga@pasteur.fr.ORCID 0000-0002-1794-4871
Broad Institute · USInstitut Pasteur · FRUniversité Paris-Sud · FR

Funding

Viral Genomics: evolution, spread, and host interactionsU19AI110818 · NIAID · BROAD INSTITUTE, INC. · PI NEAFSEY, DANIEL E · 2014 to 2024
$66.5M
GENOME MAPPING AND SEQUENCING CONFERENCER13HG000049 · NHGRI · COLD SPRING HARBOR LABORATORY · PI GRODZICKER, TERRI I. · 1990 to 2001
$81k
NHGRI NIH HHS R13 HG000049NIAID NIH HHS HHSN272200900018CNIAID NIH HHS U19 AI110818
6 · The paper itself

Abstract

backgroundClostridium bolteae and Clostridium clostridioforme, previously included in the complex C. clostridioforme in the group Clostridium XIVa, remain difficult to distinguish by phenotypic methods. These bacteria, prevailing in the human intestinal microbiota, are opportunistic pathogens with various drug susceptibility patterns. In order to better characterize the two species and to obtain information on their antibiotic resistance genes, we analyzed the genomes of six strains of C. bolteae and six strains of C. clostridioforme, isolated from human infection.

resultsThe genome length of C. bolteae varied from 6159 to 6398 kb, and 5719 to 6059 CDSs were detected. The genomes of C. clostridioforme were smaller, between 5467 and 5927 kb, and contained 5231 to 5916 CDSs. The two species display different metabolic pathways. The genomes of C. bolteae contained lactose operons involving PTS system and complex regulation, which contribute to phenotypic differentiation from C. clostridioforme. The Acetyl-CoA pathway, similar to that of Faecalibacterium prausnitzii, a major butyrate producer in the human gut, was only found in C. clostridioforme. The two species have also developed diverse flagella mobility systems contributing to gut colonization. Their genomes harboured many CDSs involved in resistance to beta-lactams, glycopeptides, macrolides, chloramphenicol, lincosamides, rifampin, linezolid, bacitracin, aminoglycosides and tetracyclines. Overall antimicrobial resistance genes were similar within a species, but strain-specific resistance genes were found. We discovered a new group of genes coding for rifampin resistance in C. bolteae. C. bolteae 90B3 was resistant to phenicols and linezolide in producing a 23S rRNA methyltransferase. C. clostridioforme 90A8 contained the VanB-type Tn1549 operon conferring vancomycin resistance. We also detected numerous genes encoding proteins related to efflux pump systems.

conclusionGenomic comparison of C. bolteae and C. clostridiofrome revealed functional differences in butyrate pathways and in flagellar systems, which play a critical role within human microbiota. Most of the resistance genes detected in both species were previously characterized in other bacterial species. A few of them were related to antibiotics inactive against Clostridium spp. Some were part of mobile genetic elements suggesting that these commensals of the human microbiota act as reservoir of antimicrobial resistances.

Indexed as

Genome, BacterialGenomicsAnti-Bacterial AgentsBiosynthetic PathwaysButyratesClostridiumDrug Resistance, BacterialHumansPhylogenyAnti-Bacterial AgentsButyratesAntimicrobial resistanceButyrate pathwayClostridium bolteaeClostridium clostridioformeComparative genomics

Identifiers

PMID27769168
PMCPMC5073890
OpenAlexW2535360044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.